# A Phase I/IIa AERAS-456 in HIV-Negative Adults With & Without Latent Tuberculosis Infection (C-035-456)

> **NCT01865487** · PHASE1,PHASE2 · COMPLETED · sponsor: **Aeras** · enrollment: 98 (actual)

## Conditions studied

- Latent Tuberculosis Bacteriology and Histology Unknown
- Latent Tuberculosis

## Interventions

- **BIOLOGICAL:** H56ug/IC31nmol
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT01865487
- **Lead sponsor:** Aeras
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2015-08
- **Final completion:** 2015-11
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2019-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01865487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01865487, "A Phase I/IIa AERAS-456 in HIV-Negative Adults With & Without Latent Tuberculosis Infection (C-035-456)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01865487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
